TIDMAGY

RNS Number : 7390T

Allergy Therapeutics PLC

08 October 2014

8 October 2014

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

Directorate Change

Allergy Therapeutics plc (AIM: AGY), the fully integrated speciality pharmaceutical company specialising in allergy vaccines, announces that Alejandro Esteban Weinstein Manieu has stepped down from the Board with immediate effect.

Peter Jensen, Chairman of the Board, said: "Alejandro has made an enormous contribution to the development of Allergy Therapeutics since his involvement in 2009 and I would like to take this opportunity to thank him for his valuable guidance and support."

For further information

 
  Allergy Therapeutics                     +44 (0) 1903 845 820 
  Manuel Llobet, Chief Executive 
   Officer 
   Ian Postlethwaite, Finance Director 
 
  Peel Hunt LLP                            +44 (0) 20 7418 8900 
  James Steel 
   Clare Terlouw 
 
  FTI Consulting                           +44 (0) 20 3727 1000 
  Simon Conway 
   Victoria Foster Mitchell

Notes to editors

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of GBP42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into the Emerging Markets

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAUGGWCUUPCUQR

Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Allergy Therapeutics Charts.
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Allergy Therapeutics Charts.